Global Furosemide Market Growth 2020-2025
According to this study, over the next five years the Furosemide market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Furosemide business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Furosemide market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Furosemide, covering the supply chain analysis, impact assessment to the Furosemide market size growth rate in several scenarios, and the measures to be undertaken by Furosemide companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Injection
Solution
Tablet
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Pharmacy
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi Aventis
US Pharm Holdings
Sandoz
Hospira
Mylan
Emcure Pharms
West-Ward Pharms
Sun Pharm Inds
Ivax Sub Teva Pharms
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Furosemide consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Furosemide market by identifying its various subsegments.
Focuses on the key global Furosemide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Furosemide with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Furosemide submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Furosemide Consumption 2015-2025
2.1.2 Furosemide Consumption CAGR by Region
2.2 Furosemide Segment by Type
2.2.1 Injection
2.2.2 Solution
2.2.3 Tablet
2.3 Furosemide Consumption by Type
2.3.1 Global Furosemide Consumption Market Share by Type (2015-2020)
2.3.2 Global Furosemide Revenue and Market Share by Type (2015-2020)
2.3.3 Global Furosemide Sale Price by Type (2015-2020)
2.4 Furosemide Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Clinics
2.4.4 Others
2.5 Furosemide Consumption by Application
2.5.1 Global Furosemide Consumption Market Share by Type (2015-2020)
2.5.2 Global Furosemide Value and Market Share by Type (2015-2020)
2.5.3 Global Furosemide Sale Price by Type (2015-2020)
3 Global Furosemide by Company
3.1 Global Furosemide Sales Market Share by Company
3.1.1 Global Furosemide Sales by Company (2018-2020)
3.1.2 Global Furosemide Sales Market Share by Company (2018-2020)
3.2 Global Furosemide Revenue Market Share by Company
3.2.1 Global Furosemide Revenue by Company (2018-2020)
3.2.2 Global Furosemide Revenue Market Share by Company (2018-2020)
3.3 Global Furosemide Sale Price by Company
3.4 Global Furosemide Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Furosemide Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Furosemide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Furosemide by Regions
4.1 Furosemide by Regions
4.2 Americas Furosemide Consumption Growth
4.3 APAC Furosemide Consumption Growth
4.4 Europe Furosemide Consumption Growth
4.5 Middle East & Africa Furosemide Consumption Growth
5 Americas
5.1 Americas Furosemide Consumption by Countries
5.1.1 Americas Furosemide Consumption by Countries (2015-2020)
5.1.2 Americas Furosemide Value by Countries (2015-2020)
5.2 Americas Furosemide Consumption by Type
5.3 Americas Furosemide Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Furosemide Consumption by Regions
6.1.1 APAC Furosemide Consumption by Regions (2015-2020)
6.1.2 APAC Furosemide Value by Regions (2015-2020)
6.2 APAC Furosemide Consumption by Type
6.3 APAC Furosemide Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Furosemide by Countries
7.1.1 Europe Furosemide Consumption by Countries (2015-2020)
7.1.2 Europe Furosemide Value by Countries (2015-2020)
7.2 Europe Furosemide Consumption by Type
7.3 Europe Furosemide Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Furosemide by Countries
8.1.1 Middle East & Africa Furosemide Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Furosemide Value by Countries (2015-2020)
8.2 Middle East & Africa Furosemide Consumption by Type
8.3 Middle East & Africa Furosemide Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Furosemide Distributors
10.3 Furosemide Customer
11 Global Furosemide Market Forecast
11.1 Global Furosemide Consumption Forecast (2021-2025)
11.2 Global Furosemide Forecast by Regions
11.2.1 Global Furosemide Forecast by Regions (2021-2025)
11.2.2 Global Furosemide Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Furosemide Forecast by Type
11.8 Global Furosemide Forecast by Application
12 Key Players Analysis
12.1 Sanofi Aventis
12.1.1 Company Information
12.1.2 Furosemide Product Offered
12.1.3 Sanofi Aventis Furosemide Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Sanofi Aventis Latest Developments
12.2 US Pharm Holdings
12.2.1 Company Information
12.2.2 Furosemide Product Offered
12.2.3 US Pharm Holdings Furosemide Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 US Pharm Holdings Latest Developments
12.3 Sandoz
12.3.1 Company Information
12.3.2 Furosemide Product Offered
12.3.3 Sandoz Furosemide Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Sandoz Latest Developments
12.4 Hospira
12.4.1 Company Information
12.4.2 Furosemide Product Offered
12.4.3 Hospira Furosemide Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Hospira Latest Developments
12.5 Mylan
12.5.1 Company Information
12.5.2 Furosemide Product Offered
12.5.3 Mylan Furosemide Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Mylan Latest Developments
12.6 Emcure Pharms
12.6.1 Company Information
12.6.2 Furosemide Product Offered
12.6.3 Emcure Pharms Furosemide Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Emcure Pharms Latest Developments
12.7 West-Ward Pharms
12.7.1 Company Information
12.7.2 Furosemide Product Offered
12.7.3 West-Ward Pharms Furosemide Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 West-Ward Pharms Latest Developments
12.8 Sun Pharm Inds
12.8.1 Company Information
12.8.2 Furosemide Product Offered
12.8.3 Sun Pharm Inds Furosemide Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Sun Pharm Inds Latest Developments
12.9 Ivax Sub Teva Pharms
12.9.1 Company Information
12.9.2 Furosemide Product Offered
12.9.3 Ivax Sub Teva Pharms Furosemide Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Ivax Sub Teva Pharms Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Furosemide Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Injection
Table 5. Major Players of Solution
Table 6. Major Players of Tablet
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Furosemide Consumption Market Share by Type (2015-2020)
Table 9. Global Furosemide Revenue by Type (2015-2020) ($ million)
Table 10. Global Furosemide Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Furosemide Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Furosemide Consumption Market Share by Application (2015-2020)
Table 14. Global Furosemide Value by Application (2015-2020)
Table 15. Global Furosemide Value Market Share by Application (2015-2020)
Table 16. Global Furosemide Sale Price by Application (2015-2020)
Table 17. Global Furosemide Sales by Company (2017-2019) (MT)
Table 18. Global Furosemide Sales Market Share by Company (2017-2019)
Table 19. Global Furosemide Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Furosemide Revenue Market Share by Company (2017-2019)
Table 21. Global Furosemide Sale Price by Company (2017-2019)
Table 22. Global Furosemide Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Furosemide Products Offered
Table 24. Furosemide Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Furosemide Consumption by Regions 2015-2020 (MT)
Table 26. Global Furosemide Consumption Market Share by Regions 2015-2020
Table 27. Global Furosemide Value by Regions 2015-2020 ($ Millions)
Table 28. Global Furosemide Value Market Share by Regions 2015-2020
Table 29. Americas Furosemide Consumption by Countries (2015-2020) (MT)
Table 30. Americas Furosemide Consumption Market Share by Countries (2015-2020)
Table 31. Americas Furosemide Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Furosemide Value Market Share by Countries (2015-2020)
Table 33. Americas Furosemide Consumption by Type (2015-2020) (MT)
Table 34. Americas Furosemide Consumption Market Share by Type (2015-2020)
Table 35. Americas Furosemide Consumption by Application (2015-2020) (MT)
Table 36. Americas Furosemide Consumption Market Share by Application (2015-2020)
Table 37. APAC Furosemide Consumption by Regions (2015-2020) (MT)
Table 38. APAC Furosemide Consumption Market Share by Regions (2015-2020)
Table 39. APAC Furosemide Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Furosemide Value Market Share by Regions (2015-2020)
Table 41. APAC Furosemide Consumption by Type (2015-2020) (MT)
Table 42. APAC Furosemide Consumption Market Share by Type (2015-2020)
Table 43. APAC Furosemide Consumption by Application (2015-2020) (MT)
Table 44. APAC Furosemide Consumption Market Share by Application (2015-2020)
Table 45. Europe Furosemide Consumption by Countries (2015-2020) (MT)
Table 46. Europe Furosemide Consumption Market Share by Countries (2015-2020)
Table 47. Europe Furosemide Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Furosemide Value Market Share by Countries (2015-2020)
Table 49. Europe Furosemide Consumption by Type (2015-2020) (MT)
Table 50. Europe Furosemide Consumption Market Share by Type (2015-2020)
Table 51. Europe Furosemide Consumption by Application (2015-2020) (MT)
Table 52. Europe Furosemide Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Furosemide Consumption by Countries (2015-2020) (MT)
Table 54. Middle East & Africa Furosemide Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Furosemide Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Furosemide Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Furosemide Consumption by Type (2015-2020) (MT)
Table 58. Middle East & Africa Furosemide Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Furosemide Consumption by Application (2015-2020) (MT)
Table 60. Middle East & Africa Furosemide Consumption Market Share by Application (2015-2020)
Table 61. Furosemide Distributors List
Table 62. Furosemide Customer List
Table 63. Global Furosemide Consumption Forecast by Countries (2021-2025) (MT)
Table 64. Global Furosemide Consumption Market Forecast by Regions
Table 65. Global Furosemide Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Furosemide Value Market Share Forecast by Regions
Table 67. Global Furosemide Consumption Forecast by Type (2021-2025) (MT)
Table 68. Global Furosemide Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Furosemide Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Furosemide Value Market Share Forecast by Type (2021-2025)
Table 71. Global Furosemide Consumption Forecast by Application (2021-2025) (MT)
Table 72. Global Furosemide Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Furosemide Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Furosemide Value Market Share Forecast by Application (2021-2025)
Table 75. Sanofi Aventis Product Offered
Table 76. Sanofi Aventis Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 77. Sanofi Aventis Main Business
Table 78. Sanofi Aventis Latest Developments
Table 79. Sanofi Aventis Basic Information, Company Total Revenue (in $ million), Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 80. US Pharm Holdings Product Offered
Table 81. US Pharm Holdings Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 82. US Pharm Holdings Main Business
Table 83. US Pharm Holdings Latest Developments
Table 84. US Pharm Holdings Basic Information, Company Total Revenue (in $ million), Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 85. Sandoz Product Offered
Table 86. Sandoz Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 87. Sandoz Main Business
Table 88. Sandoz Latest Developments
Table 89. Sandoz Basic Information, Company Total Revenue (in $ million), Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 90. Hospira Product Offered
Table 91. Hospira Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 92. Hospira Main Business
Table 93. Hospira Latest Developments
Table 94. Hospira Basic Information, Company Total Revenue (in $ million), Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 95. Mylan Product Offered
Table 96. Mylan Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 97. Mylan Main Business
Table 98. Mylan Latest Developments
Table 99. Mylan Basic Information, Company Total Revenue (in $ million), Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 100. Emcure Pharms Product Offered
Table 101. Emcure Pharms Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 102. Emcure Pharms Main Business
Table 103. Emcure Pharms Latest Developments
Table 104. Emcure Pharms Basic Information, Company Total Revenue (in $ million), Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 105. West-Ward Pharms Product Offered
Table 106. West-Ward Pharms Basic Information, Company Total Revenue (in $ million), Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 107. West-Ward Pharms Main Business
Table 108. West-Ward Pharms Latest Developments
Table 109. West-Ward Pharms Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 110. Sun Pharm Inds Product Offered
Table 111. Sun Pharm Inds Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 112. Sun Pharm Inds Main Business
Table 113. Sun Pharm Inds Latest Developments
Table 114. Sun Pharm Inds Basic Information, Company Total Revenue (in $ million), Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 115. Ivax Sub Teva Pharms Product Offered
Table 116. Ivax Sub Teva Pharms Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 117. Ivax Sub Teva Pharms Main Business
Table 118. Ivax Sub Teva Pharms Latest Developments
Table 119. Ivax Sub Teva Pharms Basic Information, Company Total Revenue (in $ million), Furosemide Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Furosemide
Figure 2. Furosemide Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Furosemide Consumption Growth Rate 2015-2025 (MT)
Figure 5. Global Furosemide Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Injection
Figure 7. Product Picture of Solution
Figure 8. Product Picture of Tablet
Figure 9. Global Furosemide Consumption Market Share by Type (2015-2020)
Figure 10. Global Furosemide Value Market Share by Type (2015-2020)
Figure 11. Furosemide Consumed in Hospital
Figure 12. Global Furosemide Market: Hospital (2015-2020) (MT)
Figure 13. Global Furosemide Market: Hospital (2015-2020) ($ Millions)
Figure 14. Furosemide Consumed in Pharmacy
Figure 15. Global Furosemide Market: Pharmacy (2015-2020) (MT)
Figure 16. Global Furosemide Market: Pharmacy (2015-2020) ($ Millions)
Figure 17. Furosemide Consumed in Clinics
Figure 18. Global Furosemide Market: Clinics (2015-2020) (MT)
Figure 19. Global Furosemide Market: Clinics (2015-2020) ($ Millions)
Figure 20. Furosemide Consumed in Others
Figure 21. Global Furosemide Market: Others (2015-2020) (MT)
Figure 22. Global Furosemide Market: Others (2015-2020) ($ Millions)
Figure 23. Global Furosemide Consumption Market Share by Application (2015-2020)
Figure 24. Global Furosemide Value Market Share by Application (2015-2020)
Figure 25. Global Furosemide Sales Market Share by Company in 2017
Figure 26. Global Furosemide Sales Market Share by Company in 2019
Figure 27. Global Furosemide Revenue Market Share by Company in 2017
Figure 28. Global Furosemide Revenue Market Share by Company in 2019
Figure 29. Global Furosemide Sale Price by Company in 2019
Figure 30. Global Furosemide Consumption Market Share by Regions 2015-2020
Figure 31. Global Furosemide Value Market Share by Regions 2015-2020
Figure 32. Americas Furosemide Consumption 2015-2020 (MT)
Figure 33. Americas Furosemide Value 2015-2020 ($ Millions)
Figure 34. APAC Furosemide Consumption 2015-2020 (MT)
Figure 35. APAC Furosemide Value 2015-2020 ($ Millions)
Figure 36. Europe Furosemide Consumption 2015-2020 (MT)
Figure 37. Europe Furosemide Value 2015-2020 ($ Millions)
Figure 38. Middle East & Africa Furosemide Consumption 2015-2020 (MT)
Figure 39. Middle East & Africa Furosemide Value 2015-2020 ($ Millions)
Figure 40. Americas Furosemide Consumption Market Share by Countries in 2019
Figure 41. Americas Furosemide Value Market Share by Countries in 2019
Figure 42. Americas Furosemide Consumption Market Share by Type in 2019
Figure 43. Americas Furosemide Consumption Market Share by Application in 2019
Figure 44. United States Furosemide Consumption Growth 2015-2020 (MT)
Figure 45. United States Furosemide Value Growth 2015-2020 ($ Millions)
Figure 46. Canada Furosemide Consumption Growth 2015-2020 (MT)
Figure 47. Canada Furosemide Value Growth 2015-2020 ($ Millions)
Figure 48. Mexico Furosemide Consumption Growth 2015-2020 (MT)
Figure 49. Mexico Furosemide Value Growth 2015-2020 ($ Millions)
Figure 50. APAC Furosemide Consumption Market Share by Countries in 2019
Figure 51. APAC Furosemide Value Market Share by Regions in 2019
Figure 52. APAC Furosemide Consumption Market Share by Type in 2019
Figure 53. APAC Furosemide Consumption Market Share by Application in 2019
Figure 54. China Furosemide Consumption Growth 2015-2020 (MT)
Figure 55. China Furosemide Value Growth 2015-2020 ($ Millions)
Figure 56. Japan Furosemide Consumption Growth 2015-2020 (MT)
Figure 57. Japan Furosemide Value Growth 2015-2020 ($ Millions)
Figure 58. Korea Furosemide Consumption Growth 2015-2020 (MT)
Figure 59. Korea Furosemide Value Growth 2015-2020 ($ Millions)
Figure 60. Southeast Asia Furosemide Consumption Growth 2015-2020 (MT)
Figure 61. Southeast Asia Furosemide Value Growth 2015-2020 ($ Millions)
Figure 62. India Furosemide Consumption Growth 2015-2020 (MT)
Figure 63. India Furosemide Value Growth 2015-2020 ($ Millions)
Figure 64. Australia Furosemide Consumption Growth 2015-2020 (MT)
Figure 65. Australia Furosemide Value Growth 2015-2020 ($ Millions)
Figure 66. Europe Furosemide Consumption Market Share by Countries in 2019
Figure 67. Europe Furosemide Value Market Share by Countries in 2019
Figure 68. Europe Furosemide Consumption Market Share by Type in 2019
Figure 69. Europe Furosemide Consumption Market Share by Application in 2019
Figure 70. Germany Furosemide Consumption Growth 2015-2020 (MT)
Figure 71. Germany Furosemide Value Growth 2015-2020 ($ Millions)
Figure 72. France Furosemide Consumption Growth 2015-2020 (MT)
Figure 73. France Furosemide Value Growth 2015-2020 ($ Millions)
Figure 74. UK Furosemide Consumption Growth 2015-2020 (MT)
Figure 75. UK Furosemide Value Growth 2015-2020 ($ Millions)
Figure 76. Italy Furosemide Consumption Growth 2015-2020 (MT)
Figure 77. Italy Furosemide Value Growth 2015-2020 ($ Millions)
Figure 78. Russia Furosemide Consumption Growth 2015-2020 (MT)
Figure 79. Russia Furosemide Value Growth 2015-2020 ($ Millions)
Figure 80. Middle East & Africa Furosemide Consumption Market Share by Countries in 2019
Figure 81. Middle East & Africa Furosemide Value Market Share by Countries in 2019
Figure 82. Middle East & Africa Furosemide Consumption Market Share by Type in 2019
Figure 83. Middle East & Africa Furosemide Consumption Market Share by Application in 2019
Figure 84. Egypt Furosemide Consumption Growth 2015-2020 (MT)
Figure 85. Egypt Furosemide Value Growth 2015-2020 ($ Millions)
Figure 86. South Africa Furosemide Consumption Growth 2015-2020 (MT)
Figure 87. South Africa Furosemide Value Growth 2015-2020 ($ Millions)
Figure 88. Israel Furosemide Consumption Growth 2015-2020 (MT)
Figure 89. Israel Furosemide Value Growth 2015-2020 ($ Millions)
Figure 90. Turkey Furosemide Consumption Growth 2015-2020 (MT)
Figure 91. Turkey Furosemide Value Growth 2015-2020 ($ Millions)
Figure 92. GCC Countries Furosemide Consumption Growth 2015-2020 (MT)
Figure 93. GCC Countries Furosemide Value Growth 2015-2020 ($ Millions)
Figure 94. Global Furosemide Consumption Growth Rate Forecast (2021-2025) (MT)
Figure 95. Global Furosemide Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 96. Americas Furosemide Consumption 2021-2025 (MT)
Figure 97. Americas Furosemide Value 2021-2025 ($ Millions)
Figure 98. APAC Furosemide Consumption 2021-2025 (MT)
Figure 99. APAC Furosemide Value 2021-2025 ($ Millions)
Figure 100. Europe Furosemide Consumption 2021-2025 (MT)
Figure 101. Europe Furosemide Value 2021-2025 ($ Millions)
Figure 102. Middle East & Africa Furosemide Consumption 2021-2025 (MT)
Figure 103. Middle East & Africa Furosemide Value 2021-2025 ($ Millions)
Figure 104. United States Furosemide Consumption 2021-2025 (MT)
Figure 105. United States Furosemide Value 2021-2025 ($ Millions)
Figure 106. Canada Furosemide Consumption 2021-2025 (MT)
Figure 107. Canada Furosemide Value 2021-2025 ($ Millions)
Figure 108. Mexico Furosemide Consumption 2021-2025 (MT)
Figure 109. Mexico Furosemide Value 2021-2025 ($ Millions)
Figure 110. Brazil Furosemide Consumption 2021-2025 (MT)
Figure 111. Brazil Furosemide Value 2021-2025 ($ Millions)
Figure 112. China Furosemide Consumption 2021-2025 (MT)
Figure 113. China Furosemide Value 2021-2025 ($ Millions)
Figure 114. Japan Furosemide Consumption 2021-2025 (MT)
Figure 115. Japan Furosemide Value 2021-2025 ($ Millions)
Figure 116. Korea Furosemide Consumption 2021-2025 (MT)
Figure 117. Korea Furosemide Value 2021-2025 ($ Millions)
Figure 118. Southeast Asia Furosemide Consumption 2021-2025 (MT)
Figure 119. Southeast Asia Furosemide Value 2021-2025 ($ Millions)
Figure 120. India Furosemide Consumption 2021-2025 (MT)
Figure 121. India Furosemide Value 2021-2025 ($ Millions)
Figure 122. Australia Furosemide Consumption 2021-2025 (MT)
Figure 123. Australia Furosemide Value 2021-2025 ($ Millions)
Figure 124. Germany Furosemide Consumption 2021-2025 (MT)
Figure 125. Germany Furosemide Value 2021-2025 ($ Millions)
Figure 126. France Furosemide Consumption 2021-2025 (MT)
Figure 127. France Furosemide Value 2021-2025 ($ Millions)
Figure 128. UK Furosemide Consumption 2021-2025 (MT)
Figure 129. UK Furosemide Value 2021-2025 ($ Millions)
Figure 130. Italy Furosemide Consumption 2021-2025 (MT)
Figure 131. Italy Furosemide Value 2021-2025 ($ Millions)
Figure 132. Russia Furosemide Consumption 2021-2025 (MT)
Figure 133. Russia Furosemide Value 2021-2025 ($ Millions)
Figure 134. Spain Furosemide Consumption 2021-2025 (MT)
Figure 135. Spain Furosemide Value 2021-2025 ($ Millions)
Figure 136. Egypt Furosemide Consumption 2021-2025 (MT)
Figure 137. Egypt Furosemide Value 2021-2025 ($ Millions)
Figure 138. South Africa Furosemide Consumption 2021-2025 (MT)
Figure 139. South Africa Furosemide Value 2021-2025 ($ Millions)
Figure 140. Israel Furosemide Consumption 2021-2025 (MT)
Figure 141. Israel Furosemide Value 2021-2025 ($ Millions)
Figure 142. Turkey Furosemide Consumption 2021-2025 (MT)
Figure 143. Turkey Furosemide Value 2021-2025 ($ Millions)
Figure 144. GCC Countries Furosemide Consumption 2021-2025 (MT)
Figure 145. GCC Countries Furosemide Value 2021-2025 ($ Millions)
Figure 146. Sanofi Aventis Furosemide Market Share (2018-2020)
Figure 147. US Pharm Holdings Furosemide Market Share (2018-2020)
Figure 148. Sandoz Furosemide Market Share (2018-2020)
Figure 149. Hospira Furosemide Market Share (2018-2020)
Figure 150. Mylan Furosemide Market Share (2018-2020)
Figure 151. Emcure Pharms Furosemide Market Share (2018-2020)
Figure 152. West-Ward Pharms Furosemide Market Share (2018-2020)
Figure 153. Sun Pharm Inds Furosemide Market Share (2018-2020)
Figure 154. Ivax Sub Teva Pharms Furosemide Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets